The Board has determined that the VA medical opinions obtained in November and December 2021 are insufficient to address whether the Veteran's loss of bone density, pain, and joint/muscle pain of the hips and back were caused by or worsened due to her use of Anastrozole for treatment of left breast cancer. The Board has therefore remanded the case for further development.
The deciding factor: The VA medical opinions did not address whether the Veteran's loss of bone density, pain, and joint/muscle pain of the hips and back were caused by or worsened due to her use of Anastrozole for treatment of left breast cancer.
- Claimed conditions
- loss of bone density, bone pain, joint/muscle pain of the hips and back
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- September 12, 2024
- Citation
- A24055985
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A24055985.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Board denied the Veteran's claim for service connection for bone pain, including as due to bone density loss related to osteoporosis and osteopenia or related to arthritis and degenerative disc disease. The VA examiners concluded that these conditions did not clearly pre-exist service, were not incurred in service, and are not aggravated by service.
- Granted
The Veteran's service connection claim for multiple myeloma is granted. The Board also grants service connection for anxiety, bone pain, depression, erectile dysfunction, joint pain, keloid scars, left upper and lower extremity conditions, and right upper and lower extremity conditions as secondary to multiple myeloma.
- Remanded (sent back)
The Board has remanded several issues related to the Veteran's claims, including chronic weakness, celiac disease, weight loss, dyslipidemia, polymyalgia rheumatoid, loss of bone density, and SVT. The issues are being remanded for further development as VA examinations are needed to determine if these conditions are due to Agent Orange exposure.
- Granted
The Veteran's nonischemic coronary artery disease (CAD) is presumed to be related to herbicide agent exposure during service in Vietnam. The claim for bone pain is remanded and requires further examination.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.